Publication date: July 2018
Source:Surgical Oncology Clinics of North America, Volume 27, Issue 3
Author(s): Enusha Karunasena, Jonathan Sham, Kevin Wyatt McMahon, Nita Ahuja
Teaser
The peritoneum protects the intraabdominal organs. This function is exploited by aggressive cancers originating from organs within the abdomen, resulting in peritoneal metastasis. We discuss genomic variants that may lead to peritoneal metastasis from multiple cancers. Peritoneal malignancies are attributed to epithelial-mesenchymal transition. These metastatic lesions harbor similar genetic mutations to the primary tumor yet may manifest clone-specific aberrations that promote propagation. Peritoneal metastasis are increasingly being treated with surgical resection as an adjunct to radiation, chemotherapy, and other biologic therapies. We describe genetic and genomic variances that are predictive markers for metastasis and burgeoning indicators for peritoneal malignancies.https://ift.tt/2lnysFS
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου